John Sullivan was quoted in Corporate Counsel's recent article on the U.S. Food and Drug Administration's safety alert last week about the vulnerability to hacking of up to 750,000 implantable heart defibrillators. John explained to the publication that it is premature to speculate on possible lawsuits because no adverse events have been reported. “It is hard to see a mass tort in this, but that doesn’t mean there won’t eventually be limited efforts by attorneys interested in bringing single claims or a few claims. I foresee a lot of viable defenses," John said. 

To read the full article, click here.